For Hp treatment, first-line therapy is a combination of amoxicillin (AMX), a proton pump inhibitor (PPI), and clarithromycin (CLR) in areas with low CLR resistance. In regions with high CLR resistance (>15%), metronidazole, AMX, PPI, and CLR or bismuth quadruple therapy are recommended.